Clinical Trials Logo

Hypervascular Tumors clinical trials

View clinical trials related to Hypervascular Tumors.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04523350 Active, not recruiting - Clinical trials for Hypervascular Tumors

Instylla HES Hypervascular Tumor Pivotal Study

Start date: January 4, 2021
Phase: N/A
Study type: Interventional

To determine whether Instylla HES has the ability to effectively embolize targeted arterial segments of hypervascular tumors as well as (i.e., is non-inferior to) standard of care (SOC) transarterial embolization/conventional transarterial chemoembolization, while resulting in an acceptable risk of device and procedure-related serious adverse events.